CJ BIO Announces Participation in IFT 2025, Showcasing Taste Innovation Rooted in Quality and Authenticity
DOWNERS GROVE, Ill., June 25, 2025 /PRNewswire/ -- CJ BIO is proud to announce its fourth consecutive participation in the Institute of Food Technologists (IFT) First Annual Event and Expo, taking place in Chicago this July. Since rejoining the...
CJ 4DPLEX Achieves Record-Breaking May Box Office in North America
LOS ANGELES, June 6, 2025 /PRNewswire/ -- CJ 4DPLEX, the world's leading producer of premium film formats, announced today the company's highest-ever domestic box office results for the month of May in both 4DX and SCREENX formats. 4DX generated...
First NDIN-Completed Akkermansia muciniphila for Muscle Health: BiomeNrich™ POST M005
CHICAGO, March 26, 2025 /PRNewswire/ -- CJ BIO's BiomeNrich™ POST M005 is the first Akkermansia muciniphila-based ingredient to receive New Dietary Ingredient Notification (NDIN) acknowledgment from the U.S. Food and Drug Administration (FDA). This...
CJ Bioscience to Present Preclinical Data on Inflammatory Bowel Disease Pipeline Candidate CJRB-201 at 'ECCO 2025'; Clinical Entry Targeted for 2026
'CJRB-201', a proprietary strain of Faecalibacterium with potent its anti-inflammatory effects, has demonstrated the strongest induction of regulatory T cells (Tregs) among analyzed strains. Preclinical studies in multiple animal models confirm...
CJ 4DPLEX Appoints Jun Bang as New CEO
Bang is the youngest ever CEO to be appointed within the CJ Group of Companies SEOUL, South Korea and HOLLYWOOD, Calif., Dec. 5, 2024 /PRNewswire/ -- CJ 4DPLEX, the world's leading producer of premium film formats and cinema technologies, announced...